Orange County Global Medical Center, INC
Orange County Global Medical Center, INC was paid $8.60M by Medicaid between Jan 2018 and Dec 2024, across 216 billing codes. Its largest line is 0450, Emergency room services — 8.3% of everything it billed.
SANTA ANA, CA 92705
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 86,654 | $939K | |
| 2019 | 75,804 | $1.24M | |
| 2020 | 69,496 | $836K | |
| 2021 | 78,394 | $936K | |
| 2022 | 96,785 | $1.31M | |
| 2023 | 90,522 | $1.56M | |
| 2024incomplete | 68,146 | $1.77M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 8.3% | 50,903 | 44,771 | $717K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8.2% | 4,181 | 3,856 | $708K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.3% | 12,340 | 10,951 | $539K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 6.1% | 9,041 | 6,443 | $528K |
| Z7502 | 4.9% | 11,190 | 11,015 | $426K | |
| 70450 | Computed tomography, head or brain; without contrast material | 3.8% | 6,849 | 6,317 | $324K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3.8% | 8,318 | 6,674 | $324K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.2% | 3,185 | 2,945 | $274K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 34,865 | 29,442 | $228K |
| 59025 | Fetal non-stress test | 2.6% | 12,260 | 4,220 | $226K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2.6% | 6,022 | 2,857 | $220K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 15,571 | 13,784 | $217K |
204 more codes
| 80053 | Comprehensive metabolic panel | 2.4% | 27,310 | $205K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 8,489 | $198K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.2% | 2,717 | $192K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 8,565 | $164K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 8,946 | $160K |
| Z9725 | 1.4% | 2,943 | $120K | |
| 99199 | Unlisted special service, procedure or report | 1.4% | 2,057 | $116K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 13,275 | $109K |
| J3490 | Unclassified drugs | 1.3% | 23,684 | $108K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 2,774 | $106K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,572 | $105K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.0% | 2,296 | $89K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,047 | $82K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,935 | $73K |
| 72131 | <1% | 1,195 | $72K | |
| 84484 | <1% | 9,488 | $67K | |
| 0160 | <1% | 2,174 | $65K | |
| 76801 | <1% | 1,429 | $65K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,302 | $64K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,023 | $60K |
| 72128 | <1% | 906 | $60K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,179 | $54K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 384 | $50K |
| 83690 | <1% | 10,190 | $49K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,087 | $48K |
| 83880 | <1% | 2,126 | $48K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,198 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,934 | $45K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,899 | $44K |
| 90715 | <1% | 1,658 | $44K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,523 | $40K |
| 81001 | <1% | 17,287 | $39K | |
| 70486 | <1% | 553 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,961 | $35K |
| 99283 | Emergency room visit (moderate) | <1% | 3,202 | $35K |
| 81025 | <1% | 12,303 | $34K | |
| 76830 | Ultrasound, transvaginal | <1% | 703 | $33K |
| 87631 | <1% | 890 | $32K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,105 | $30K |
| Z7610 | <1% | 2,954 | $29K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 981 | $28K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,896 | $28K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,904 | $27K |
| 0270 | <1% | 29,553 | $25K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 425 | $22K |
| 85730 | <1% | 5,621 | $21K | |
| 99285 | Emergency room visit (most serious) | <1% | 459 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,596 | $20K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,122 | $20K |
| 93458 | <1% | 29 | $19K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,632 | $19K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,906 | $19K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,809 | $18K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,325 | $18K |
| 93971 | <1% | 188 | $17K | |
| 83735 | <1% | 4,000 | $17K | |
| 85610 | <1% | 6,585 | $17K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,950 | $16K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,951 | $16K |
| 84702 | <1% | 2,023 | $16K | |
| 82550 | <1% | 3,537 | $15K | |
| 82948 | <1% | 5,466 | $14K | |
| 93308 | <1% | 174 | $14K | |
| 0360 | <1% | 4,929 | $13K | |
| 95816 | <1% | 329 | $13K | |
| 83605 | <1% | 1,876 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,050 | $12K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,570 | $11K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,552 | $11K |
| 99284 | Emergency room visit (serious) | <1% | 696 | $11K |
| 86901 | <1% | 4,857 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,068 | $10K |
| 86900 | <1% | 4,858 | $10K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 58 | $10K |
| 73630 | <1% | 584 | $9K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,956 | $9K |
| 86850 | <1% | 3,694 | $9K | |
| 87040 | <1% | 1,027 | $9K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 86 | $8K |
| 80061 | Lipid panel | <1% | 1,056 | $8K |
| 82803 | <1% | 689 | $8K | |
| 73610 | <1% | 497 | $8K | |
| 73130 | <1% | 505 | $7K | |
| G0390 | Trauma response team associated with hospital critical care service | <1% | 256 | $7K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,351 | $7K |
| 82330 | <1% | 608 | $7K | |
| 87186 | <1% | 990 | $7K | |
| 85027 | <1% | 1,402 | $6K | |
| 73564 | <1% | 361 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 113 | $6K |
| J1815 | Injection, insulin, per 5 units | <1% | 634 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 123 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,400 | $5K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 400 | $5K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 16 | $5K |
| 0762 | <1% | 1,422 | $4K | |
| 71250 | <1% | 79 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 931 | $4K |
| 82553 | <1% | 667 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 385 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 266 | $4K |
| 73030 | <1% | 190 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 778 | $4K |
| 72170 | <1% | 234 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 503 | $3K |
| 97750 | <1% | 87 | $2K | |
| 88342 | <1% | 271 | $2K | |
| 0250 | <1% | 2,898 | $2K | |
| 0710 | <1% | 3,174 | $2K | |
| 80305 | <1% | 231 | $2K | |
| 58661 | <1% | 12 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 280 | $2K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 187 | $2K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 320 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 108 | $2K |
| 87077 | <1% | 262 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 46 | $2K |
| 84295 | <1% | 524 | $2K | |
| 84132 | <1% | 518 | $2K | |
| 82947 | <1% | 519 | $1K | |
| 84703 | <1% | 566 | $1K | |
| 87650 | <1% | 82 | $1K | |
| 97139 | <1% | 97 | $1K | |
| 73020 | <1% | 130 | $1K | |
| 93017 | <1% | 32 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 54 | $1K |
| 10060 | <1% | 113 | $1K | |
| 85380 | <1% | 399 | $1K | |
| 80047 | <1% | 348 | $1K | |
| 99152 | <1% | 250 | $1K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 135 | $1K |
| 96376 | <1% | 605 | $1K | |
| 85014 | <1% | 552 | $959.14 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 180 | $950.72 |
| 85018 | <1% | 547 | $938.28 | |
| 82150 | <1% | 307 | $879.48 | |
| 71010 | <1% | 77 | $843.77 | |
| 73560 | <1% | 67 | $793.23 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 58 | $741.00 |
| 88307 | <1% | 39 | $739.17 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 87 | $700.03 |
| 84145 | <1% | 51 | $624.00 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 89 | $544.17 |
| 94664 | <1% | 65 | $527.79 | |
| 0760 | <1% | 2,010 | $511.50 | |
| J2358 | Injection, olanzapine, long-acting, 1 mg | <1% | 88 | $505.66 |
| 97116 | <1% | 74 | $479.15 | |
| Z7500 | <1% | 14 | $477.40 | |
| 0300 | <1% | 1,939 | $435.22 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $420.00 |
| 73590 | <1% | 31 | $418.45 | |
| 88313 | <1% | 63 | $384.87 | |
| 73110 | <1% | 26 | $365.15 | |
| 81003 | <1% | 158 | $347.79 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 82 | $344.85 |
| 82570 | <1% | 67 | $340.03 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,762 | $339.42 |
| 84550 | <1% | 83 | $333.21 | |
| 81002 | <1% | 359 | $323.46 | |
| 29125 | <1% | 82 | $306.84 | |
| 87210 | <1% | 70 | $288.88 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 63 | $285.30 |
| 80076 | <1% | 81 | $245.86 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 46 | $237.97 |
| 74018 | <1% | 14 | $234.47 | |
| 73080 | <1% | 14 | $210.89 | |
| 87147 | <1% | 55 | $205.61 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 145 | $198.40 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 32 | $187.74 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 71 | $184.20 |
| 87070 | <1% | 27 | $182.66 | |
| 84156 | <1% | 52 | $173.07 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 24 | $159.96 |
| 87420 | <1% | 86 | $140.37 | |
| 0100U | <1% | 293 | $122.73 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 38 | $121.62 |
| 88302 | <1% | 13 | $118.24 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 115 | $107.21 |
| 84460 | <1% | 20 | $104.87 | |
| 84450 | <1% | 20 | $101.27 | |
| 97162 | <1% | 45 | $90.06 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 17 | $65.79 |
| 12001 | <1% | 14 | $62.40 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 16 | $54.60 |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 17 | $39.52 |
| 0510 | <1% | 132 | $34.10 | |
| 97161 | <1% | 15 | $33.68 | |
| 99001 | <1% | 928 | $17.30 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 59 | $8.09 |
| 0636 | <1% | 249 | $2.18 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 12 | $0.66 |
| 0272 | <1% | 260 | $0.04 | |
| 0402 | 0% | 146 | $0.00 | |
| 0260 | 0% | 271 | $0.00 | |
| 0351 | 0% | 54 | $0.00 | |
| 77002 | 0% | 12 | $0.00 | |
| 76818 | 0% | 26 | $0.00 | |
| 0320 | 0% | 83 | $0.00 | |
| 0352 | 0% | 111 | $0.00 | |
| 0370 | 0% | 236 | $0.00 | |
| 80320 | 0% | 88 | $0.00 | |
| 0310 | 0% | 56 | $0.00 | |
| 0324 | 0% | 136 | $0.00 | |
| 80329 | 0% | 154 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| KPC Global Medical Centers, INC. | Hemet, CA | $29.34M |
| Victor Valley Hospital Acquisition, INC. | Victorville, CA | $26.63M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| Anaheim Global Medical Center, INC | Anaheim, CA | $4.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $3.98M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| Chapman Global Medical Center, INC | Orange, CA | $761K |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.